These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16957755)

  • 1. Gene expression profiling of thyroid tumors--clinical applicability.
    Lubitz CC; Fahey TJ
    Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):472-3. PubMed ID: 16957755
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
    Murphy KM; Chen F; Clark DP
    Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in the clinical application of thyroid cancer biomarkers.
    Shibru D; Chung KW; Kebebew E
    Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
    Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
    Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from early clinical experience with the Afirma gene expression classifier.
    Krane JF
    Cancer Cytopathol; 2014 Oct; 122(10):715-9. PubMed ID: 25123593
    [No Abstract]   [Full Text] [Related]  

  • 7. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy.
    Fontaine JF; Mirebeau-Prunier D; Franc B; Triau S; Rodien P; Houlgatte R; Malthièry Y; Savagner F
    Oncogene; 2008 Apr; 27(15):2228-36. PubMed ID: 17968324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide studies in thyroid neoplasia.
    Giordano TJ
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):311-31, vii-viii. PubMed ID: 18502329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of differentiated thyroid cancer. Towards the application in clinical practice.
    Rousset B
    Ann Endocrinol (Paris); 2008 Apr; 69(2):135-7. PubMed ID: 18417091
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and molecular classification of hepatocellular carcinoma.
    Llovet JM
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S13-6. PubMed ID: 17969094
    [No Abstract]   [Full Text] [Related]  

  • 12. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
    Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
    J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cDNA microarrays: identification of gene signatures and their application in clinical practice.
    Magic Z; Radulovic S; Brankovic-Magic M
    J BUON; 2007 Sep; 12 Suppl 1():S39-44. PubMed ID: 17935276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
    Miller LD; Liu ET
    Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.
    Griffith OL; Melck A; Jones SJ; Wiseman SM
    J Clin Oncol; 2006 Nov; 24(31):5043-51. PubMed ID: 17075124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New, clinically relevant molecular characterizations of thyroid cancer.
    Davis PJ
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):359-60. PubMed ID: 19654539
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
    Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
    Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
    Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling as a tool for basic analysis and clinical application of human cancer.
    García-Escudero R; Paramio JM
    Mol Carcinog; 2008 Aug; 47(8):573-9. PubMed ID: 18324660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.